hESC Patents Piece from San Diego Researchers
The foray by the California stem cell agency into the tricky and arcane world of patent reform triggered a note today from the acting director of the San Diego Consortium for Regenerative Medicine, Xuejun H. Parsons.
She pointed out that the San Diego Regenerative Medicine Institute has a short piece on its web site about the patentability of human embry…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.